Jun 14, 2013 Analyst Moves: SO, MYGN - Marketnewsvideo.Com
Jun 14, 2013 Ban on patenting DNA cheers researchers - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 14, 2013 Benzinga`s Top Downgrades - Benzinga
Jun 14, 2013 Benzinga`s Top Pre-Market Losers - Benzinga
Jun 14, 2013 Central Texan among patients who sued Myriad Genetics - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 14, 2013 Downgrade Alert for Myriad Genetics (MYGN) - Comtex Smartrend(R)
Jun 14, 2013 Downgrade Alert for Myriad Genetics (MYGN) - Comtex Smartrend(R)
Jun 14, 2013 EDITORIAL: Thumbs up, thumbs down - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 14, 2013 Fitch: DNA Patent Decision Benign for Pharmaceutical Ratings - Businesswire
Jun 14, 2013 Mid-Afternoon Market Update: Walter Energy Plummets as Oil Posts a Strong Rally - Benzinga
Jun 14, 2013 Mid-Day Market Update: Stocks Move Lower, Groupon Rises on Analyst Upgrade - Benzinga
Jun 14, 2013 Mid-Morning Market Update: Markets Slightly Higher, Smithfield Posts Lower Profit - Benzinga
Jun 14, 2013 Myriad Ruling Causes 15 Percent Swing Thursday ??? Here`s Why - Benzinga
Jun 14, 2013 Myriad Stock Slips As Analysts Debate Patent Impact - Investors Business Daily
Jun 14, 2013 Myriad`s Bearish Dive Shows Biotech Leaders Stalling - Investors Business Daily
Jun 14, 2013 Reveal Insider Trading for Safeway, Facebook, Cisco, Citigroup, Elan, and Myriad Genetics - Pr Newswire
Jun 14, 2013 Shares of Myriad Genetics Under Pressure, Down 7.5% - Financial News Network Online - Market Movers
Jun 14, 2013 Stocks Edge Off Lows In Late Trading; Myriad Plunges - Investors Business Daily
Jun 14, 2013 Stocks Give Back A Portion Of Prior Day`s Big Gains - Investors Business Daily
Jun 14, 2013 Stocks Give Back A Portion Of Prior Day`s Big Gains - Investors Business Daily
Jun 14, 2013 Stocks Lower At Midday After Erasing Early Gains - Investors Business Daily
Jun 14, 2013 Stocks Open Mildly Higher; Myriad Continues To Slide - Investors Business Daily
Jun 14, 2013 Supreme Court Upholds Myriad's cDNA Patent Claims - M2
Jun 14, 2013 Supreme Court: Companies cannot obtain patents for human genes - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 14, 2013 UPDATE: Bank of America Downgrades Myriad Genetics as Competitive Concerns Emerge - Benzinga
Jun 14, 2013 Upgrade Alert for Myriad Genetics (MYGN) - Comtex Smartrend(R)
Jun 14, 2013 Wall Street Realizes Myriad Genetics Monopoly on Breast Cancer Risk Tests Is Done - TheStreet.com
Jun 14, 2013 Why Myriad Genetics Shares Swooned Again - TheMotleyFool
Jun 14, 2013 `Happy Birthday` the Subject of Newest Copyright Litigation - Benzinga
Jun 13, 2013 AAPS Applauds Supreme Court's Respect for Medical Innovation - Pr Newswire
Jun 13, 2013 AMP Celebrates SCOTUS Decision on AMP v. Myriad Case - Pr Newswire
Jun 13, 2013 After Yesterday's Decline of 5.63%, Myriad Genetics Offers Investors Better Value - Comtex Smartrend(R)
Jun 13, 2013 Afternoon Market Gainers - Benzinga
Jun 13, 2013 BIO Statement On U.S. Supreme Court Review Of Isolated DNA Patents - Businesswire
Jun 13, 2013 BRIEF: Central Texan among patients who sued Myriad Genetics - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 13, 2013 BRIEF: Supreme Court: No patenting human genes unless they are changed - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 13, 2013 Breast Cancer Action Wins: SCOTUS Overturns Human Gene Patents - Pr Newswire
Jun 13, 2013 Court Upholds Myriad Genetics` Patent Claim - TheMotleyFool
Jun 13, 2013 Court: Our Genes, Ourselves - Investors Business Daily
Jun 13, 2013 FRC Praises Supreme Court Decision on DNA - Pr Newswire
Jun 13, 2013 GeneDx to Launch Comprehensive Breast Cancer Genetic Test - Cnw Group
Jun 13, 2013 GeneDx to Launch Comprehensive Breast Cancer Genetic Test - Pr Newswire
Jun 13, 2013 GeneDx to Launch Comprehensive Breast Cancer Genetic Test - Pr Newswire Europe
Jun 13, 2013 Market Wrap for Thursday, June 13: Strong Economic Reports Trigger Stock Rally - Benzinga
Jun 13, 2013 Myriad Genetics Set to Possibly Rebound After Yesterday's Selloff of 5.63% - Comtex Smartrend(R)
Jun 13, 2013 Myriad Genetics Shares Rise on Supreme Court Gene Patent Ruling - TheStreet.com
Jun 13, 2013 Myriad Genetics Stock Jumps On Supreme Court Ruling - Investors Business Daily
Jun 13, 2013 Myriad Genetics Up 8% on Supreme Court Ruling - YCharts
Jun 13, 2013 Myriad shares soar 10% after Supreme Court ruling on genes - CNNMoney
Jun 13, 2013 Myriad`s Bearish Dive Shows Biotec Leaders Stalling - Investors Business Daily
Jun 13, 2013 Recent 52-Week High Exceeded in Shares of Myriad Genetics (MYGN) - Financial News Netwfork Online - 52-Week High-Lows
Jun 13, 2013 SCOTUS: You Can`t Patent a Gene -- Sort Of - FOXBusiness.com
Jun 13, 2013 Shares of Myriad Genetics Are Moving Higher on 7.2x Above-Average Volume (MYGN) - Financial News Network Online - Unusual Volume
Jun 13, 2013 Statement Of Dr. Jennifer Howse, President, March Of Dimes On The Supreme Court Decision Related To Gene Patenting - Pr Newswire
Jun 13, 2013 Stocks Extend Gains In Late Trade; Myriad Genetics Up - Investors Business Daily
Jun 13, 2013 Stocks Stage Huge Comeback; Myriad Turns Tail - Investors Business Daily
Jun 13, 2013 Supreme Court Upholds Myriad's cDNA Patent Claims - Globenewswire
Jun 13, 2013 Supreme Court rules human genes cannot be patented - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 13, 2013 Supreme Court rules human genes cannot be patented - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 13, 2013 Supreme Court ruling a game changer for patients? Doctors weigh in - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 13, 2013 Supreme Court: No patenting human genes unless they are changed - Mcclatchy-Tribune Information Services -- Unrestricted
Jun 13, 2013 Supreme Court: You Can`t Patent a Gene -- Sort Of - FOXBusiness.com
Jun 13, 2013 U.S. stocks end more than 1% higher - CNNMoney
Jun 13, 2013 U.S. stocks glide higher - CNNMoney
Jun 13, 2013 U.S. stocks jump 1% - CNNMoney
Jun 12, 2013 Myriad Genetics (MYGN) Showing Bullish Technicals With Resistance At $35.08 - Freshbrewedmedia
Jun 12, 2013 Zimmer Stays at Neutral - Zacks.Com
Jun 11, 2013 AstraZeneca to use Myriad's BRACAnalysis test - Datamonitor
Jun 10, 2013 22.4% Return Seen to Date on SmarTrend Myriad Genetics Call (MYGN) - Comtex Smartrend(R)
Jun 10, 2013 Myriad Genetics Shares Climbing Higher, Up 2.0% - Financial News Network Online - Market Movers
Jun 7, 2013 Analyst Rating In Review: Myriad Genetics Sold Off 3.5% Since Downgraded 7 Days Ago (MYGN) - Financial News Network Online - News Corner
Jun 7, 2013 Bullish Moving Average Cross by Myriad Genetics (MYGN) - Financial News Network Online - Moving Average Crossovers
Jun 7, 2013 UPDATE: Cantor Fitzgerald Initiates Coverage on Myriad Genetics on Position in Molecular Diagnostic Franchises - Benzinga
Jun 6, 2013 Baron Funds Comments on Myriad Genetics Inc. - GuruFocus
Jun 6, 2013 Myriad Genetics (MYGN) Showing Bullish Technicals With Resistance At $32.04 - Freshbrewedmedia
Jun 5, 2013 Judgment Day for Myriad Genetics - TheMotleyFool
Jun 5, 2013 Stock Investors Sell Off Shares of Myriad Genetics, Down 2.5% - Financial News Network Online - Market Movers
Jun 3, 2013 Myriad Genetics to Present at the Goldman Sachs Global Healthcare Conference - Globenewswire
Jun 3, 2013 Shares of MYGN Up 18.1% Since Uptrend Call on Shares - Comtex Smartrend(R)
Jun 1, 2013 AstraZeneca Advances PARP Inhibitor Into Phase 3 Trial With BRACAnalysis(R) - Globenewswire
May 31, 2013 Analyst Moves: SMG, PANW, MYGN - Marketnewsvideo.Com
May 31, 2013 Downgrade Alert for Myriad Genetics (MYGN) - Comtex Smartrend(R)
May 31, 2013 Myriad Genetics (MYGN) Showing Bullish Technicals But Could Fall Through $31.46 Support - Freshbrewedmedia
May 31, 2013 Myriad Genetics Bullish Moving Average Crossover Alert (MYGN) - Financial News Network Online - Moving Average Crossovers
May 31, 2013 UPDATE: Jefferies Assumes Coverage on Myriad Genetics, Downgrades to Hold Ahead of SCOTUS Decision - Benzinga
May 30, 2013 Myriad Genetics to Present PROLARIS(R) Data at ASCO 2013, Continuing Its Commitment to Cancer Research - Globenewswire
May 28, 2013 Buyers Accumulate Shares of Myriad Genetics, Up 3.3% - Financial News Network Online - Market Movers
May 24, 2013 Myriad Genetics Shares Up 15.8% Since SmarTrend's Buy Recommendation (MYGN) - Comtex Smartrend(R)
